Login
$LWAY
$18.32 +$0.26 (1.44%) After hours

$LWAY 8-K SEC Filings

Filed On Filing
12 Nov 2026 8-K: Results of Operations and Financial Condition

28th consecutive quarter of year-over-year net sales growth; year-to-date 2026 net sales up 25.8%

13 Aug 2026 8-K: Results of Operations and Financial Condition

$66.9 million in net sales, up 24.1% year-over-year and $3.9 million above the prior quarterly record

07 Jul 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

This Master Security Agreement, dated as of June 30, 2026 (as the same may from time to time be amended, restated, modified or supplemented, this “MSA”), is entered into by and between LIFEWAY FOODS, INC., an Illinois corporation (“Custo...

18 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure

Forward Looking Statements 2 This presentation contains “forward - looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product ...

05 Jun 2026 8-K: Termination of a Material Definitive Agreement; Material Modification to Rights of Security Holders

The information set forth in Item 3.03 below is incorporated by reference in this Item 1.02.

03 Jun 2026 8-K: Other Events

On April 30, 2026 Lifeway Foods, Inc. (the “Company) filed a definitive proxy statement (the “Proxy Statement”) with the Securities and Exchange Commission (the “SEC”) for the solicitation of proxies in connection with the annual meeting...

14 May 2026 8-K: Entry into a Material Definitive Agreement; Other Events

Danone USA Public Benefit Corporation, a Delaware public benefit corporation (the “Selling Stockholder”), proposes to sell to BTIG, LLC (“BTIG”), as the sole underwriter (the “Underwriter,” which term shall also include any underwriter s...

14 May 2026 8-K: Results of Operations and Financial Condition

Achieves $63.0 million in net sales, a 37% volume-led net sales increase, driven by the Company’s flagship Lifeway Kefir

01 Apr 2026 8-K: Results of Operations and Financial Condition

MORTON GROVE, Ill., April 1, 2026 – Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or the “Company”), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today provided preliminary financial outl...

17 Mar 2026 8-K: Results of Operations and Financial Condition

Company achieves full year 2025 net sales of $212.5 million; up 19% year-over-year on a comparable basis

11 Mar 2026 8-K: Departure/Election of Directors or Officers; Compensation

This AWARD, made as of the __h day of _______, 20__, by Lifeway Foods, Inc., an Illinois corporation (the “Company”), to ____________ (“Participant”), is made pursuant to and subject to the provisions of the Lifeway Foods, Inc. 2022 Omni...

08 Jan 2026 8-K: Results of Operations and Financial Condition

Morton Grove, IL — January 8, 2026 — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic foods, today announced that the Company will participate in the ICR Conferen...

31 Dec 2025 8-K: Submission of Matters to a Vote of Security Holders

The 2025 Annual Meeting of Shareholders (the “Annual Meeting”) of Lifeway Foods, Inc. (the “Company”) was held on December 29, 2025. There were 15,228,763 shares of common stock outstanding and entitled to vote at the Annual Meeting and ...

30 Dec 2025 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

This Sixth Modification to Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into effective as of December 29, 2025 (the “Effective Date”) by and among CIBC BANK USA (the “Lender”), LIFEWAY FOODS, INC., an Il...

29 Dec 2025 8-K: Regulation FD Disclosure

Forward Looking Statements 2 This presentation contains “forward - looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product ...

01 Dec 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure +1 more

Lifeway Issues Letter to Shareholders Regarding Dissident Director Nominees, Revealing Disqualifying Track Records and Ethical Failures

12 Nov 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Achieves $57.1 million in net sales, a 29% volume-led net sales increase on a comparable basis, driven by the Company’s flagship Lifeway Kefir

07 Nov 2025 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

04 Nov 2025 8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year

These Second Amended and Restated Bylaws (the “Bylaws”) of Lifeway Foods, Inc. (the “Corporation”) are hereby amended as of October 29, 2025 by the Board of Directors of the Corporation (the “Board of Directors”).

30 Oct 2025 8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +1 more

Morton Grove, Ill. — October 29, 2025 — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or the “Company”), the leading U.S. supplier of kefir and fermented probiotic products that support the microbiome, today announced that its Board of D...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support